Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company developing novel peptide-based therapeutics for liver and cardiometabolic diseases, today announced an oral presentation ...

T1D Exchange, a nonprofit organization that drives meaningful research and improvement in care and outcomes in type 1 ...

Its annual Scientific Sessions set the agenda for clinical practice and research innovation. The 85th Scientific Sessions of ADA will be held in Chicago, U.S. from June 20 to 23, 2025. About ...

It has grown into one of the foremost nonprofit organizations in diabetes advocacy around the world. Its annual Scientific Sessions set the agenda for clinical practice and research innovation. The ...

Drawing on data from the organization's Registry of more than 20,000 people with T1D, several presentations offer insights into clinical outcomes as well as the broader impact of the disease ...

Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") announces that poster presentations on preliminary studies of its oral small molecule GLP-1 Receptor (GLP-1R) agonist ASC30 and adipose-targeted, ...

Her Royal Highness The Princess Royal attended the 2025 Meet the Researcher Showcase, hosted by Medical Research Scotland at ...

A Lancaster County science fair champion has earned international honors for developing a fishing lure that won’t contribute ...

A Lancaster County science fair champion has earned international honors for developing a fishing lure that won’t contribute ...

Neuralink's Blindsight implant enabled a monkey to perceive nonexistent objects by stimulating vision-related brain areas, as revealed by engineer Joseph O'Doherty. The company aims to help blind ...